Cannell & Co’s Avanos Medical AVNS Stock Holding History

Cannell & Co’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-16,826	Closed	-$583K	–	251
2016 Q3	$583K	Sell	16,826 -219	-1%	-$7.67K	0.02%	196
2016 Q2	$554K	Hold	17,045	–	–	0.02%	200
2016 Q1	$490K	Sell	17,045 -2,500	-13%	-$66.6K	0.02%	205
2015 Q4	$653K	Sell	19,545 -2,562	-12%	-$79.7K	0.02%	194
2015 Q3	$629K	Sell	22,107 -1,994	-8%	-$69.6K	0.02%	200
2015 Q2	$976K	Buy	24,101 +851	+4%	+$38.2K	0.03%	173
2015 Q1	$1.14M	Buy	23,250 +640	+3%	+$29.6K	0.03%	169
2014 Q4	$1.03M	Buy	+22,610	New	+$888K	0.03%	171

Other funds holding AVNS

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return